KATE SNYDER: Open Payments
NPI 1114310711 · COLLIERVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,267 in 66 payments from 15 companies in 2025. Trend: 2023 $206 · 2024 $851 · 2025 $1,267
Food & beverage: $1,267
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $368 |
| Lilly USA, LLC | 10 | $200 |
| ABBVIE INC. | 12 | $181 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 3 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Abbott Laboratories | 2 | $41 |
| Dexcom, Inc. | 2 | $35 |
Products named: MOUNJARO, Wegovy, Ozempic, UBRELVY, Kerendia, QULIPTA, Auvelity, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
